OS Therapies (OSTX) 推进三期试验设计,市场定价反映增长预期

· gurufocus.com

2026年9月15日,OS Therapies Inc (OSTX) 宣布已与英国药品和医疗保健产品监管局(MHRA)就三期试验设计达成全面协议

On September 15, 2026, OS Therapies Inc OSTX announced it has reached full agreement with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) on...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI